Dry Eye

• Do not use if you are allergic to MIEBO.
• Remove contact lenses before using MIEBO® and wait for at least 30 minutes before reinserting.
• It is important to use MIEBO® exactly as prescribed.
• It is not known if MIEBO® is safe and effective in children under the age of 18.
• In pivotal trials the most common eye side effect seen in studies was blurred vision (1% to 3% of patients reported blurred vision and eye redness). 

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch  or call 1-800-FDA-1088.

 Download full Prescribing Information for MIEBO^®

• XIIDRA® is contraindicated in patients with known hypersensitivity to lifitegrast or to any of the other ingredients.
• In clinical trials, the most common adverse reactions reported in 5-25% of patients were instillation site irritation, dysgeusia and reduced visual acuity. Other adverse reactions reported in 1% to 5% of the patients were blurred vision, conjunctival hyperemia, eye irritation, headache, increased lacrimation, eye discharge, eye discomfort, eye pruritus and sinusitis.
• To avoid the potential for eye injury or contamination of the solution, patients should not touch the tip of the single-use container to their eye or to any surface.
• Contact lenses should be removed prior to the administration of XIIDRA® and may be reinserted 15 minutes following administration.
• Safety and efficacy in pediatric patients below the age of 17 years have not been established.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch  or call 1-800-FDA-1088.

 Download full Prescribing Information for XIIDRA®